The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kronenfeld Mark A. since year 2005.
The trader's CIK number is 1578074.
At the time of this reporting, Kronenfeld Mark A. is the Director of Pacira Pharmaceuticals, Inc. .
(stock ticker symbol PCRX).
See this page for all insider trading activities at Pacira Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-06||PCRX||Pacira Pharmaceuticals, Inc.||Buy||1,700||38.93||66,181|
|2018-08-28||PCRX||Pacira Pharmaceuticals, Inc.||Buy||1,000||44.61||44,611|
|2017-11-10||PCRX||Pacira Pharmaceuticals, Inc.||Buy||1,000||41.60||41,603|
|2016-06-06||PCRX||Pacira Pharmaceuticals, Inc.||Sale||900||46.95||42,255|
|2014-11-03||PCRX||Pacira Pharmaceuticals, Inc.||Buy||850||90.48||76,908|
|2013-09-11||PCRX||Pacira Pharmaceuticals, Inc.||Buy||1,000||37.01||37,010|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kronenfeld Mark A. (Director of Pacira Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.